新时代我国基本药物制度发展趋势研究  

Research on the development trend of China's essential drug system in the new era

作　　者：张海涛 ZHANG Haitao(School of Public Administration,Nanjing Audit University,Nanjing Jiangsu 211815,China)

机构地区：[1]南京审计大学公共管理学院,江苏南京211815

出　　处：《卫生软科学》2024年第4期15-18,23,共5页Soft Science of Health

基　　金：国家社会科学基金一般项目-“纪监审”协同机制研究(23BDJ030);江苏省审计厅课题(2023JSSJY008)。

摘　　要：基本药物制度作为现阶段我国医药卫生体制改革的突破口,在药品供应领域存在药品供应短缺与结构失衡的问题,在药品使用领域存在用药安全与用药失范问题。主要原因包括基本药物制度法制不健全、有关监测与激励机制不完善、质量管理机制落实不到位以及医患主体的滞后性等。建议进一步完善基本药物制度法制建设,切实完善、落实企业及医疗机构有关监测、激励机制,进一步推动基本药物一致性评价,构建药物合理使用的长效机制,以促进基本药物制度的进一步发展和完善。As a breakthrough in the reform of Chinas medical and health system at the present stage,the essential drug system has problems of shortage of drug supply and structural imbalance in the field of drug supply,and problems of drug safety and drug misuse in the field of drug use.The main reasons include the imperfect legal system of essential drug system,the imperfect monitoring and incentive mechanism,the inadequate implementation of quality management mechanism and the lag of doctor-patient main body.It is suggested to further improve the legal construction of essential drug system,effectively improve and implement the relevant monitoring and incentive mechanisms for enterprises and medical institutions,further promote the consistency evaluation of essential drugs,and build a long-term mechanism for the rational use of drugs,so as to promote the further development and improvement of the essential drug system.

关 键 词：基本药物制度 药品供应 药物合理使用 

分 类 号：R197.1[医药卫生—卫生事业管理]